Homologous Recombination Deficiency Testing to Inform Patient Decisions About Niraparib Maintenance Therapy for High-Grade Serous or Endometrioid Epithelial Ovarian Cancer: A Health Technology Assessment.
OA: closed
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
SciLite annotations
chemicals 17
niraparib
niraparib
niraparib
niraparib
niraparib
niraparib
niraparib
niraparib
platinum
taxane
olaparib
niraparib
pandamarilactone 31
rucaparib
veliparib
nucleotide
adenosine 5'-monophosphate
organisms 3
human
homo heidelbergensis
noordeloos 2009062
Source provenance
- europepmc
- last seen: 2026-06-17T06:13:18.893374+00:00
- scilite
- last seen: 2026-05-18T04:25:29.313245+00:00